[go: up one dir, main page]

MX2013002372A - Metodos para recelularizar un tejido o un organo para una transplantabilidad mejorada. - Google Patents

Metodos para recelularizar un tejido o un organo para una transplantabilidad mejorada.

Info

Publication number
MX2013002372A
MX2013002372A MX2013002372A MX2013002372A MX2013002372A MX 2013002372 A MX2013002372 A MX 2013002372A MX 2013002372 A MX2013002372 A MX 2013002372A MX 2013002372 A MX2013002372 A MX 2013002372A MX 2013002372 A MX2013002372 A MX 2013002372A
Authority
MX
Mexico
Prior art keywords
organ
methods
tissue
cell
transplantability
Prior art date
Application number
MX2013002372A
Other languages
English (en)
Other versions
MX343363B (es
Inventor
Doris Taylor
Stefan M Kren
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of MX2013002372A publication Critical patent/MX2013002372A/es
Publication of MX343363B publication Critical patent/MX343363B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

En la presente se describen métodos para recelularizar una matriz de órgano y tejido.
MX2013002372A 2010-09-01 2011-09-01 Metodos para recelularizar un tejido o un organo para una transplantabilidad mejorada. MX343363B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37907310P 2010-09-01 2010-09-01
PCT/US2011/050266 WO2012031162A1 (en) 2010-09-01 2011-09-01 Methods of recellularizing a tissue or organ for improved transplantability

Publications (2)

Publication Number Publication Date
MX2013002372A true MX2013002372A (es) 2013-12-06
MX343363B MX343363B (es) 2016-11-03

Family

ID=44903335

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013002372A MX343363B (es) 2010-09-01 2011-09-01 Metodos para recelularizar un tejido o un organo para una transplantabilidad mejorada.

Country Status (14)

Country Link
US (4) US10233420B2 (es)
EP (1) EP2611472B1 (es)
JP (1) JP5931878B2 (es)
KR (1) KR101900116B1 (es)
CN (1) CN103458935B (es)
AU (1) AU2011295779B2 (es)
CA (1) CA2809990C (es)
ES (1) ES2562707T3 (es)
IL (1) IL224964A (es)
MX (1) MX343363B (es)
PL (1) PL2611472T3 (es)
RU (1) RU2611361C2 (es)
SG (1) SG188369A1 (es)
WO (1) WO2012031162A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2965769B1 (en) 2005-08-26 2018-12-26 Regents of the University of Minnesota Decellularization and recellularization of organs and tissues
US10233420B2 (en) 2010-09-01 2019-03-19 Regents Of The University Of Minnesota Methods of recellularizing a tissue or organ for improved transplantability
DE102011112955A1 (de) 2011-09-13 2013-03-14 Medizinische Hochschule Hannover Verfahren zur Herstellung eines biologischen Gewebekonstrukts und Verwendung spezifisch gewonnener autologer Zellen
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
US11819522B2 (en) 2012-09-19 2023-11-21 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
BR112015006055A2 (pt) 2012-09-19 2017-07-04 Microvascular Tissues Inc composições e métodos para o tratamento e prevenção de lesão tecidual e doença
US10596202B2 (en) 2012-09-19 2020-03-24 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
US9872937B2 (en) 2012-09-19 2018-01-23 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
CA2886027C (en) * 2012-09-25 2023-03-07 Yale University Differentiation of human ips cells to human alveolar type ii via definitive endoderm
HK1217663A1 (zh) 2013-01-09 2017-01-20 Harvard Apparatus Regenerative Technology, Inc. 合成支架
BR112015023642A2 (pt) * 2013-03-15 2017-07-18 Miromatrix Medical Inc uso de perfusão de fígado descelularizado para permitir recelularização de célula
KR101636954B1 (ko) 2013-11-04 2016-07-08 대한민국 재세포화된 바이오 스캐폴드 및 이의 제조방법
CN105980541A (zh) * 2014-01-22 2016-09-28 泽帕蒂卡股份有限公司 用于分离进行治疗评价和预测转移能力的侵袭性和转移性细胞的方法及装置
CN104208751A (zh) * 2014-08-19 2014-12-17 温州医科大学 一种新型肾脏去细胞生物支架的制备方法
KR102311639B1 (ko) * 2015-03-26 2021-10-12 주식회사 티앤알바이오팹 심근조직 재생용 3차원 구조체의 제조방법
CN108079384B (zh) * 2015-04-07 2021-07-06 四川蓝光英诺生物科技股份有限公司 一种包含内皮细胞的生物砖及其用途
CN104771788B (zh) * 2015-05-05 2017-08-25 北京帝康医药投资管理有限公司 一种基于大网膜脱细胞基质的组织工程皮肤及其构建方法
AU2016321301B2 (en) 2015-09-11 2022-06-02 The General Hospital Corporation Regeneration of a functional pulmonary vascular bed
EP3359641B1 (en) 2015-10-09 2020-01-08 DEKA Products Limited Partnership Fluid pumping and bioreactor system
US10945831B2 (en) 2016-06-03 2021-03-16 Musculoskeletal Transplant Foundation Asymmetric tissue graft
USD856517S1 (en) 2016-06-03 2019-08-13 Musculoskeletal Transplant Foundation Asymmetric tissue graft
CN106267345B (zh) * 2016-08-04 2019-03-26 中国人民解放军第三军医大学第一附属医院 一种具有生物活性的再生期器官去细胞生物支架的制备方法及其产品和应用
WO2018048899A1 (en) 2016-09-06 2018-03-15 Micromatrix Medical Inc. Use of resected liver serum for whole liver engineering
US11299705B2 (en) 2016-11-07 2022-04-12 Deka Products Limited Partnership System and method for creating tissue
KR20200028391A (ko) * 2017-06-12 2020-03-16 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 세포 생착용 패치 이식편 조성물
CN107185045A (zh) * 2017-07-10 2017-09-22 南通大学附属医院 再内皮化胰腺脱细胞支架及其制备方法
EP3801660A4 (en) * 2018-06-04 2022-04-20 Miromatrix Medical Inc. LIVER RECELLULARIZATION METHODS
WO2019241499A1 (en) 2018-06-13 2019-12-19 Miromatrix Medical Inc. Fistula filler and deployment system
US10813743B2 (en) 2018-09-07 2020-10-27 Musculoskeletal Transplant Foundation Soft tissue repair grafts and processes for preparing and using same
USD895812S1 (en) 2018-09-07 2020-09-08 Musculoskeletal Transplant Foundation Soft tissue repair graft
CN109464705B (zh) * 2018-11-19 2021-08-17 爱尔眼科医院集团股份有限公司 一种rpe细胞片及其应用和制备方法
US20230114297A1 (en) 2019-09-25 2023-04-13 Allosource Pre-shaped allograft implant for reconstructive surgical use and methods of manufacture and use, and tools for forming a pre-shaped allograft implant for reconstructive surgical use
CN110694114A (zh) * 2019-10-31 2020-01-17 南通大学附属医院 一种负载prp的胰腺脱细胞支架及其制备方法
US20230015009A1 (en) * 2019-12-04 2023-01-19 Miromatrix Medical Inc. Methods of Decellularization and Recellularization of Organs and Portions of Organs
WO2021163472A1 (en) * 2020-02-14 2021-08-19 The General Hospital Corporation Monitoring viability of organs for transplantation
CN113429475A (zh) * 2020-03-23 2021-09-24 成都中科奥格生物科技有限公司 一种胶原材料及其制备方法和用途
US12383657B1 (en) 2021-06-09 2025-08-12 Reprise Biomedical, Inc. Biologic matrix for a wound site and related methods
US11998662B1 (en) 2021-06-09 2024-06-04 Reprise Biomedical, Inc. Biologic matrix for a wound site and related methods
USD1101168S1 (en) 2023-08-09 2025-11-04 Allosource Acellular dermal matrix sheet allograft

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545221A (en) 1967-05-22 1970-12-08 Swenko Research & Dev Inc Apparatus for maintaining organs in vitro in a completely viable state
US3639084A (en) 1970-04-06 1972-02-01 Baxter Laboratories Inc Mechanism for control pulsatile fluid flow
DE2453363B2 (de) 1974-11-11 1976-08-26 Solco Basel AG, Birsfelden (Schweiz) Verfahren zur herstellung heterologer arterientransplantate
JPS5516016A (en) 1978-07-18 1980-02-04 Dai Ichi Kogyo Seiyaku Co Ltd Improved salt-resistant water-absorbing material
US4801299A (en) 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
JP2615110B2 (ja) 1987-12-29 1997-05-28 株式会社日立製作所 マイクロプログラムｒｏｍ
US5071741A (en) 1988-04-18 1991-12-10 Cryolife, Inc. Cryoprotective agent and its use in cryopreservation of cellular matter
US5283058A (en) 1990-08-30 1994-02-01 The General Hospital Corporation Methods for inhibiting rejection of transplanted tissue
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
AU672775B2 (en) 1992-01-21 1996-10-17 Cobe Laboratories Inc. Method of freezing cells and cell-like materials
US5518878A (en) 1993-09-15 1996-05-21 Organogenesis Inc. Cryopreservation of cultured skin or cornea equivalents with agitation
EP0781116A4 (en) 1994-09-12 1999-08-25 Advanced Tissue Sciences Inc THREE-DIMENSIONAL CULTURES OF HUMAN CELLS ON HEART VALVE FRAME AND THEIR USE
US5580714A (en) 1995-03-08 1996-12-03 Celox Laboratories, Inc. Cryopreservation solution
US5629145A (en) 1995-03-24 1997-05-13 Organ, Inc. Cryopreservation of cell suspensions
AU4659697A (en) 1996-10-03 1998-04-24 Regents Of The University Of California, The Cryopreservation of human adult and fetal pancreatic cells and human platelets
DE69827001T2 (de) 1997-04-11 2005-09-08 Cryolife, Inc. Gewebedezellularization
JPH1176400A (ja) 1997-09-09 1999-03-23 Masahito Nagaki 人工臓器
JP4222658B2 (ja) 1998-06-23 2009-02-12 テルモ株式会社 細胞支持基材、培養装置および液体処理装置
US6734018B2 (en) 1999-06-07 2004-05-11 Lifenet Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced
US6448076B2 (en) 1998-09-15 2002-09-10 The Regents Of The University Of Michigan Method for chemically acellularizing a biological tissue sample
US6432712B1 (en) 1999-11-22 2002-08-13 Bioscience Consultants, Llc Transplantable recellularized and reendothelialized vascular tissue graft
US6479064B1 (en) 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
US6376244B1 (en) 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization
US20050249816A1 (en) 1999-12-29 2005-11-10 Wake Forest University Health Services Tissue engineered liver constructs
AU5574101A (en) 2000-04-28 2001-11-12 Univ Emory Decellularized vascular prostheses
DE10021627B4 (de) 2000-05-04 2009-11-19 Corlife Gbr (Vertretungsberechtigte Gesellschafter: Prof. Dr. Alex Haverich Verfahren zur Herstellung eines vaskularisierten bioartifiziellen Gewebes und zugehöriger Versuchsreaktor
AU2001284968B2 (en) 2000-08-16 2006-12-21 Duke University Decellularized tissue engineered constructs and tissues
US6749064B1 (en) 2000-08-25 2004-06-15 Sanita L. Alrey Bag with article display aperture and support surface
EP1333870A2 (en) 2000-09-20 2003-08-13 Regeneration Technologies, Inc. Method of preparing and processing transplant tissue
IL139708A0 (en) 2000-11-15 2002-02-10 Amiel Gilad Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
DE10064948C1 (de) 2000-12-20 2002-07-11 Auto Tissue Gmbh Verfahren zur Dezellularisierung von Fremdmaterial zur Herstellung von Bioprothesen und Vorrichtung zur Durchführung des Verfahrens
WO2002063962A1 (en) 2001-02-14 2002-08-22 Hariri Robert J Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
EP1387885A1 (en) 2001-05-01 2004-02-11 Universite Du Quebec A Montreal Tridimensional biocompatible support structure for bioartificial organs and uses thereof
GB2375771A (en) 2001-05-24 2002-11-27 Univ Leeds Decellularisation of tissue implant material
EP1317934A1 (de) 2001-11-08 2003-06-11 Artiss GmbH Verfahren zur Herstellung einer azellularisierten Gewebematrix und damit erhältliche Gewebematrix
WO2003043675A1 (en) 2001-11-16 2003-05-30 Children's Medical Center Corporation Creation of tissue engineered female reproductive organs
EP1446171A1 (en) * 2001-11-16 2004-08-18 Children's Medical Center Corporation Augmentation of organ function
US20030180268A1 (en) 2002-02-05 2003-09-25 Anthony Atala Tissue engineered construct for supplementing or replacing a damaged organ
US20050130300A1 (en) 2002-04-04 2005-06-16 Daiichi Pure Chemicals Co., Ltd. Method of culturing liver cells over long time
US6790475B2 (en) 2002-04-09 2004-09-14 Wafermasters Inc. Source gas delivery
JP4149897B2 (ja) 2002-11-07 2008-09-17 学校法人 聖マリアンナ医科大学 気管移植片の調製方法および気管移植片
US20040187877A1 (en) 2002-12-04 2004-09-30 Badylak Stephen F. Method for repair of liver tissue
RU2005122008A (ru) 2002-12-13 2006-02-10 Цилаг Аг (Ch) Препараты с контролируемым высвобождением, содержащие трамадол и топирамат
US20040176855A1 (en) 2003-03-07 2004-09-09 Acell, Inc. Decellularized liver for repair of tissue and treatment of organ deficiency
JP2006223101A (ja) 2003-05-15 2006-08-31 Univ Waseda 生体組織の保持装置及びこれを用いた生体組織処理装置
WO2005118014A2 (en) 2004-06-01 2005-12-15 Medtronic, Inc. Decellurisation processes for making bioprotheses
JP3773943B2 (ja) 2004-09-24 2006-05-10 国立大学法人 東京大学 把持状態判定システム及び方法
DE102005023599A1 (de) 2005-05-18 2006-11-23 Corlife Gbr (Vertretungsberechtigte Gesellschafter: Prof. Dr. Alex Haverich Bioartifizielles Herzgewebetransplantat und Verfahren zu seiner Herstellung
WO2006126219A1 (en) 2005-05-26 2006-11-30 Fresenius Medical Care Deutschland G.M.B.H. Liver progenitor cells
US7824912B2 (en) 2005-06-23 2010-11-02 Massachusetts Institute Of Technology Methods for ex vivo propagation of adult hepatic stem cells
JP2007012869A (ja) 2005-06-30 2007-01-18 Seiko Epson Corp 集積回路装置及び電子機器
EP2965769B1 (en) 2005-08-26 2018-12-26 Regents of the University of Minnesota Decellularization and recellularization of organs and tissues
US20100093066A1 (en) 2005-08-26 2010-04-15 Regents Of The University Of Minnesota Decellularization and recellularization apparatuses and systems containing the same
AU2013224686B2 (en) 2005-08-26 2015-06-11 Miromatrix Medical Inc. Decellularization and recellularization of organs and tissues
JP4599315B2 (ja) 2006-02-23 2010-12-15 クラレメディカル株式会社 バイオ人工臓器
US7829108B2 (en) 2006-04-21 2010-11-09 Wake Forest University Health Sciences Structurally modified acellular tissue engineering scaffolds and methods of production
JP2010507462A (ja) 2006-10-23 2010-03-11 クック・バイオテック・インコーポレーテッド 増強した成分プロファイルを有する加工したｅｃｍ材料
CN101066477B (zh) 2007-05-17 2010-10-06 中国人民解放军第三军医大学 能在体捕获内皮祖细胞的生物人工血管
CA2743682A1 (en) * 2007-11-30 2009-06-11 New York Medical College Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
WO2010062911A2 (en) 2008-11-26 2010-06-03 Hurel Corporation Compositions and methods of functionally enhanced in vitro cell culture system
RU2011143730A (ru) 2009-03-31 2013-05-10 Риджентс Оф Дзе Юниверсити Оф Миннесота Децеллюляризации и рецеллюляризация органов и тканей
CN102803471A (zh) 2009-04-03 2012-11-28 艾克塞勒雷克斯公司 组织和器官移植生物反应器及其操作方法
JP5516016B2 (ja) 2010-04-23 2014-06-11 デクセリアルズ株式会社 異方導電性接着フィルム及びその製造方法
PL2588592T3 (pl) 2010-06-30 2018-07-31 Miromatrix Medical Inc. Zastosowanie decelularyzowanych poprzez perfuzję narządów do dopasowanej recelularyzacji
ES2588736T3 (es) 2010-07-16 2016-11-04 Lifeline Scientific, Inc. Métodos para aumentar rendimientos de aislamiento de productos celulares
US10233420B2 (en) 2010-09-01 2019-03-19 Regents Of The University Of Minnesota Methods of recellularizing a tissue or organ for improved transplantability
US9220733B2 (en) 2012-03-19 2015-12-29 The Regents Of The University Of California Solubilization of antigen components for removal from tissues
CN104350142A (zh) 2012-04-18 2015-02-11 海莫希尔有限责任公司 病理或生理性病况的体外模型
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
KR102417995B1 (ko) 2013-03-15 2022-07-06 미로매트릭스 메디칼 인크. 탈세포화된 기관 및 조직에 대한 마이크로입자 및 내피 세포의 용도
BR112015023642A2 (pt) 2013-03-15 2017-07-18 Miromatrix Medical Inc uso de perfusão de fígado descelularizado para permitir recelularização de célula
JP6340772B2 (ja) 2013-11-08 2018-06-13 東ソー株式会社 パラメータ変更履歴を管理可能な分析装置
US11648335B2 (en) 2014-01-31 2023-05-16 Wake Forest University Health Sciences Organ/tissue decellularization, framework maintenance and recellularization
US9924630B2 (en) 2014-11-14 2018-03-27 Luitauras Kairys Device for connecting two rakes
WO2016154447A1 (en) 2015-03-26 2016-09-29 Miromatrix Medical Inc. Gas filled decellularized extracellular matrix
WO2018048899A1 (en) 2016-09-06 2018-03-15 Micromatrix Medical Inc. Use of resected liver serum for whole liver engineering
JP6996151B2 (ja) 2017-08-04 2022-01-17 株式会社デンソー 車両用制御装置
US11419957B2 (en) 2020-03-16 2022-08-23 Ghassem Amoabediny Automated device for production of bioengineered tissues and organs based on decellularization and recellularization

Also Published As

Publication number Publication date
US20240400977A1 (en) 2024-12-05
ES2562707T3 (es) 2016-03-07
CN103458935B (zh) 2016-08-03
JP2013536738A (ja) 2013-09-26
US20190284523A1 (en) 2019-09-19
US12522802B2 (en) 2026-01-13
WO2012031162A1 (en) 2012-03-08
AU2011295779A1 (en) 2013-03-21
US11414644B2 (en) 2022-08-16
KR101900116B1 (ko) 2018-09-18
RU2013114382A (ru) 2014-10-10
US12084677B2 (en) 2024-09-10
AU2011295779B2 (en) 2015-08-27
US20230002723A1 (en) 2023-01-05
RU2611361C2 (ru) 2017-02-21
US20130156744A1 (en) 2013-06-20
SG188369A1 (en) 2013-04-30
CA2809990A1 (en) 2012-03-08
US10233420B2 (en) 2019-03-19
KR20140016234A (ko) 2014-02-07
JP5931878B2 (ja) 2016-06-08
EP2611472B1 (en) 2016-02-10
HK1187284A1 (zh) 2014-04-04
IL224964A (en) 2017-10-31
MX343363B (es) 2016-11-03
CA2809990C (en) 2021-03-02
PL2611472T3 (pl) 2017-02-28
EP2611472A1 (en) 2013-07-10
CN103458935A (zh) 2013-12-18

Similar Documents

Publication Publication Date Title
MX2013002372A (es) Metodos para recelularizar un tejido o un organo para una transplantabilidad mejorada.
BRPI1007339A2 (pt) Dispositivos médicos e métodos
UY34411A (es) Inmunoenlazantes dirigidos contra esclerostina
IL226288A (en) Articulating organ support
CL2012003385A1 (es) Tratamiento para la incontinencia.
GT201200276A (es) Combinaciones de compuestos activos
EP2547271A4 (en) DYNAMIC BONE PLATE
MX391175B (es) Macrociclos peptidomimeticos.
DK2720617T4 (da) Vævsbeholder / beholderaggregat og dertil knyttet fremgangsmåde.
MX353561B (es) Material de implante de mama de peso liviano.
BR112014010650A2 (pt) inoculantes microbianos e composições fertilizantes que compreendem os mesmos
CL2012002979A1 (es) Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona.
BR112013016037A2 (pt) composição em gel.
EP2605389A4 (en) Indirect matrix converter
EP2721520A4 (en) SELECTION DISPLAY BETWEEN RECEIVED FILES AND SOURCE FILES
EP2612610A4 (en) MEDICAL KNIFE
BR112012019626A2 (pt) estrutura de plantio e métodos.
BR112013002042A2 (pt) inibidor de tirosinase polipeptídico
CL2010000872A1 (es) Martillo medico para reflejos que incorpora sensores y transmision de datos.
UY34702A (es) Composiciones y métodos agrícolas u hortícolas
SMT201700017B (it) Combinazione, kit e metodo per ridurre la pressione intraoculare
UY33833A (es) Proteína de fusión Robo1-Fc para su uso en el tratamiento del hepatocarcinoma
IT1402519B1 (it) Manichino migliorato
PT2434874T (pt) Sistemas e métodos para preservar um órgão humano para transplante
AR086173A1 (es) Tableros de fibra impermeables

Legal Events

Date Code Title Description
FG Grant or registration